Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

The Effect of Antibody Fragments on CD25 Targeted Regulatory T Cell Near-Infrared Photoimmunotherapy.

Okada R, Maruoka Y, Furusawa A, Inagaki F, Nagaya T, Fujimura D, Choyke PL, Kobayashi H.

Bioconjug Chem. 2019 Sep 23. doi: 10.1021/acs.bioconjchem.9b00547. [Epub ahead of print]

PMID:
31498995
2.

Near-Infrared Photochemoimmunotherapy by Photoactivatable Bifunctional Antibody-Drug Conjugates Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancer.

Ito K, Mitsunaga M, Nishimura T, Saruta M, Iwamoto T, Kobayashi H, Tajiri H.

Bioconjug Chem. 2017 May 17;28(5):1458-1469. doi: 10.1021/acs.bioconjchem.7b00144. Epub 2017 Apr 26.

PMID:
28402624
3.

Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT).

Nagaya T, Nakamura Y, Sato K, Harada T, Choyke PL, Kobayashi H.

J Control Release. 2016 Jun 28;232:1-8. doi: 10.1016/j.jconrel.2016.04.003. Epub 2016 Apr 5.

4.

Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen.

Nagaya T, Sato K, Harada T, Nakamura Y, Choyke PL, Kobayashi H.

PLoS One. 2015 Aug 27;10(8):e0136829. doi: 10.1371/journal.pone.0136829. eCollection 2015.

5.

Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer.

Harada T, Nakamura Y, Sato K, Nagaya T, Okuyama S, Ogata F, Choyke PL, Kobayashi H.

Oncotarget. 2016 Nov 29;7(48):79408-79416. doi: 10.18632/oncotarget.12710.

6.

Near-Infrared Photoimmunotherapy Targeting Prostate Cancer with Prostate-Specific Membrane Antigen (PSMA) Antibody.

Nagaya T, Nakamura Y, Okuyama S, Ogata F, Maruoka Y, Choyke PL, Kobayashi H.

Mol Cancer Res. 2017 Sep;15(9):1153-1162. doi: 10.1158/1541-7786.MCR-17-0164. Epub 2017 Jun 6.

7.

Near infrared photoimmunotherapy of B-cell lymphoma.

Nagaya T, Nakamura Y, Sato K, Harada T, Choyke PL, Kobayashi H.

Mol Oncol. 2016 Nov;10(9):1404-1414. doi: 10.1016/j.molonc.2016.07.010. Epub 2016 Jul 29.

8.

Near-Infrared Photoimmunotherapy of Cancer.

Kobayashi H, Choyke PL.

Acc Chem Res. 2019 Aug 20;52(8):2332-2339. doi: 10.1021/acs.accounts.9b00273. Epub 2019 Jul 23.

9.

Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging.

Maruoka Y, Nagaya T, Nakamura Y, Sato K, Ogata F, Okuyama S, Choyke PL, Kobayashi H.

Mol Pharm. 2017 Dec 4;14(12):4628-4635. doi: 10.1021/acs.molpharmaceut.7b00731. Epub 2017 Nov 22.

10.

Photoimmunotherapy targeting prostate-specific membrane antigen: are antibody fragments as effective as antibodies?

Watanabe R, Hanaoka H, Sato K, Nagaya T, Harada T, Mitsunaga M, Kim I, Paik CH, Wu AM, Choyke PL, Kobayashi H.

J Nucl Med. 2015 Jan;56(1):140-4. doi: 10.2967/jnumed.114.149526. Epub 2014 Dec 11.

11.

Near infrared photoimmunotherapy with an anti-mesothelin antibody.

Nagaya T, Nakamura Y, Sato K, Zhang YF, Ni M, Choyke PL, Ho M, Kobayashi H.

Oncotarget. 2016 Apr 26;7(17):23361-9. doi: 10.18632/oncotarget.8025.

12.

Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody.

Nagaya T, Nakamura Y, Sato K, Harada T, Choyke PL, Hodge JW, Schlom J, Kobayashi H.

Oncotarget. 2017 Jan 31;8(5):8807-8817. doi: 10.18632/oncotarget.12410.

13.

Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody.

Nagaya T, Okuyama S, Ogata F, Maruoka Y, Knapp DW, Karagiannis SN, Fazekas-Singer J, Choyke PL, LeBlanc AK, Jensen-Jarolim E, Kobayashi H.

Oncotarget. 2018 Apr 10;9(27):19026-19038. doi: 10.18632/oncotarget.24876. eCollection 2018 Apr 10.

14.

[Near Infrared Photoimmunotherapy for Cancer].

Kobayashi H.

Gan To Kagaku Ryoho. 2019 Jan;46(1):28-33. Japanese.

PMID:
30765637
15.

Syngeneic Mouse Models of Oral Cancer Are Effectively Targeted by Anti-CD44-Based NIR-PIT.

Nagaya T, Nakamura Y, Okuyama S, Ogata F, Maruoka Y, Choyke PL, Allen C, Kobayashi H.

Mol Cancer Res. 2017 Dec;15(12):1667-1677. doi: 10.1158/1541-7786.MCR-17-0333. Epub 2017 Sep 18.

16.

Near infrared photoimmunotherapy using a fiber optic diffuser for treating peritoneal gastric cancer dissemination.

Nagaya T, Okuyama S, Ogata F, Maruoka Y, Choyke PL, Kobayashi H.

Gastric Cancer. 2019 May;22(3):463-472. doi: 10.1007/s10120-018-0871-5. Epub 2018 Aug 31.

PMID:
30171392
17.

Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.

Railkar R, Krane LS, Li QQ, Sanford T, Siddiqui MR, Haines D, Vourganti S, Brancato SJ, Choyke PL, Kobayashi H, Agarwal PK.

Mol Cancer Ther. 2017 Oct;16(10):2201-2214. doi: 10.1158/1535-7163.MCT-16-0924. Epub 2017 Jun 15.

18.

Molecularly Targeted Cancer Combination Therapy with Near-Infrared Photoimmunotherapy and Near-Infrared Photorelease with Duocarmycin-Antibody Conjugate.

Nagaya T, Gorka AP, Nani RR, Okuyama S, Ogata F, Maruoka Y, Choyke PL, Schnermann MJ, Kobayashi H.

Mol Cancer Ther. 2018 Mar;17(3):661-670. doi: 10.1158/1535-7163.MCT-17-0851. Epub 2017 Dec 13.

19.

Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor.

Sato K, Watanabe R, Hanaoka H, Harada T, Nakajima T, Kim I, Paik CH, Choyke PL, Kobayashi H.

Mol Oncol. 2014 May;8(3):620-32. doi: 10.1016/j.molonc.2014.01.006. Epub 2014 Jan 22.

20.

Improving the efficacy of Photoimmunotherapy (PIT) using a cocktail of antibody conjugates in a multiple antigen tumor model.

Nakajima T, Sano K, Choyke PL, Kobayashi H.

Theranostics. 2013 Apr 23;3(6):357-65. doi: 10.7150/thno.5908. Print 2013.

Supplemental Content

Support Center